News Article

Mark Anderson, MD, PhD, is the 2013 recipient of the UCSF Byers Award for Basic Science, granted to recognize and support the outstanding research of a mid-career faculty member within all of UCSF.

Over the next 25 years, the number of Americans with diabetes is expected to double, and the economic costs of diabetes will almost triple. The need for a cure is urgent. In the Diabetes Center at UCSF, we believe that innovative, collaborative research is the answer.

We are proud to announce that Greg Ku, MD, PhD will join both our research and clinical care teams as Assistant Professor in the Diabetes Center and as a member of the Division of Endocrinology and Metabolism in the Department of Medicine.

As part of the Diabetes Center’s mission to improve the quality of care for patients, the Madison Clinic for Pediatric Diabetes has implemented a program to assist older youth in their transition to adulthood.

UCSF Diabetes Center researchers Matthias Hebrok, PhD, and Mark Anderson, MD, PhD, have created in their labs the first functioning human thymus tissue derived from embryonic stem cells – a huge step forward in producing new cell therapies to treat numerous diseases including type 1 diabetes.

UCSF Diabetes Center offers intervention clinical trials for people with type 1 diabetes, as well as prevention studies for relatives of type 1 diabetes patients. Take the type 1 diabetes online screener to see if you or family members are eligible. More information HERE.

UCSF endocrinologist Umesh Masharani and his colleagues have dispelled a commonly held belief that chromium supplements improve insulin sensitivity and help prevent and treat diabetes.

Diabetes Center investigator Suneil Koliwad, MD, PhD, is exploring how nutritional factors may stimulate tissue inflammation and increase the risk for developing type 2 diabetes. Dr.

Center Director Matthias Hebrok, PhD, and his lab colleagues have optimized existing culture conditions to increase the number of pancreas progenitor cells and insulin-producing cells from human stem cells. Their current studies indicate that they are getting closer to generating functional beta cells for transplantation purposes.